Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piclosept in Neonatal Dacryocystitis
NCT07875517Phase 4Active, not recruiting
- Sponsor
- Kazakh Eye Research Institute
- Start
- Aug 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
A Phase 4 trial of picloxydine in dacryocystitis, congenital nasolacrimal duct obstruction (CNLDO), sponsored by Kazakh Eye Research Institute. Started Aug 2026; status: active, not recruiting.
02
Drugs
picloxydine
03
Conditions
dacryocystitiscongenital nasolacrimal duct obstruction (CNLDO)
Beyond the preview
Go deeper on NCT07875517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07875517.